Public, Private Players Should Share Genetic Test Oversight – HHS Advisers
This article was originally published in The Pink Sheet Daily
Executive Summary
Enhanced oversight of genetic tests should be shared through public/private partnerships, not just by extending FDA or CMS authority, HHS advisory committee says.